These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 22729136

  • 1. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
    Casadei L, Puca F, Emidi E, Manicuti C, Madrigale A, Piccione E.
    Arch Gynecol Obstet; 2012 Nov; 286(5):1291-7. PubMed ID: 22729136
    [Abstract] [Full Text] [Related]

  • 2. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome.
    Christin-Maitre S, Hugues JN, Recombinant FSH Study Group.
    Hum Reprod; 2003 Aug; 18(8):1626-31. PubMed ID: 12871872
    [Abstract] [Full Text] [Related]

  • 3. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodríguez Escudero FJ.
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [Abstract] [Full Text] [Related]

  • 4. Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation?
    Caserta D, Lisi F, Marci R, Ciardo F, Fazi A, Lisi R, Moscarini M.
    Gynecol Endocrinol; 2011 Nov; 27(11):862-6. PubMed ID: 21391759
    [Abstract] [Full Text] [Related]

  • 5. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N, Persico P, Di Sebastiano F, Marsiglio E, Ferrari A.
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [Abstract] [Full Text] [Related]

  • 6. Ovarian stimulation in obese and non-obese polycystic ovary syndrome using a low-dose step-up regimen with two different starting doses of recombinant follicle-stimulating hormone.
    Yildizhan R, Adali E, Kolusari A, Kurdoglu M, Yildizhan B, Sahin HG, Kamaci M.
    J Int Med Res; 2008 May; 36(6):1197-204. PubMed ID: 19094427
    [Abstract] [Full Text] [Related]

  • 7. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
    Balasch J, Fábregues F, Creus M, Puerto B, Peñarrubia J, Vanrell JA.
    Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212
    [Abstract] [Full Text] [Related]

  • 8. A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization.
    Koundouros SN.
    Fertil Steril; 2008 Sep; 90(3):569-75. PubMed ID: 17880950
    [Abstract] [Full Text] [Related]

  • 9. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
    Ergür AR, Yergök YZ, Ertekin A, Küçük T, Müngen E, Tütüncü L.
    J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
    De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N, Mollo A, Italian Collaborative Group on Recombinant Human Luteinizing Hormone.
    Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S, Schipper I, de Jong FH, Themmen AP, Visser JA, Laven JS.
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S, Falbo A, Di Cello A, Cappiello F, Tolino A, Zullo F.
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [Abstract] [Full Text] [Related]

  • 19. Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study.
    Seckin B, Yumusak OH, Tokmak A.
    J Obstet Gynaecol; 2021 Nov; 41(8):1234-1239. PubMed ID: 33624571
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.